Hydreight Technologies to Present at Maxim Group’s 2025 Virtual Tech Conference & the CEM Bermuda Capital Event

Core Insights - Hydreight Technologies Inc. is a rapidly growing digital health platform focused on transforming mobile and telehealth services in the U.S. [1] - The company will present at two investor conferences in June 2025, showcasing its healthcare infrastructure and technology platform [1][2] - Recent financial results indicate significant growth, with adjusted revenue increasing by 31% year-over-year [6] Financial Performance - FY2024 Adjusted Revenue reached $22.32 million CAD, a 31% increase year-over-year [6] - GAAP Revenue was reported at $16.04 million CAD, reflecting a 39% year-over-year growth [6] - Adjusted EBITDA improved to +$490,000 CAD, compared to a loss of -$1.38 million CAD in FY2023 [6] - Cash Flow from Operations was positive at +$857,000 CAD, with a current cash position of $6.8 million CAD [6] Business Expansion - In 2024, Hydreight expanded its service offerings to include Liraglutide, NAD+, TRT, peptide therapies, and oral weight-loss medications [4] - The company secured strategic partnerships with national health franchises and clinical experts, enhancing its service capabilities [4] - Hydreight has sold over 400 licenses to direct-to-consumer (D2C) brands across all 50 states, indicating strong market penetration [6] Technology and Platform Development - The VSDHOne platform was developed to facilitate compliant entry for companies into the online healthcare space, significantly reducing launch time and costs [9] - Hydreight's platform supports a network of over 3,000 nurses and 200 physicians, providing a comprehensive mobile clinic network across the U.S. [8] - The platform includes integrated tools for accounting, documentation, sales, inventory, and patient data management, enhancing operational efficiency for healthcare professionals [8]